The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Exclusion Criteria

• •Known allergy to any constituent of the vaccine.
• •* Known acute illness, severe chronic disease, acute exacerbation of chronic disease and fever.
• •* Known or suspected impairment of immunologic function, or receipt of immunosuppressive therapy or immunoglobulin since birth.
• •* Reported the history of allergies, convulsions, epilepsy, mental illness and brain disease and clear serious systemic reaction.
• •* Known bleeding disorder.
• •* Receipt of the whole blood, blood plasma or immunoglobulin before the trial vaccination.
• •* Reported the history of acute illness had need systemic antibiotics or antiviral treatment of infections in the 7 days preceding the trial vaccination.
• •* An acute illness with or without fever (temperature ≥ 38.0#) in the 3 days preceding enrollment in the trial.
• •* Participation in any other intervention clinical trial.
• •* Any condition which, in the opinion of the investigator, would pose a health risk to the subject or interfere with the vaccine.